Board of Directors

AllerGen NCE Inc. is governed by an independent Board of Directors (BoD) committed to the vision and mission of the Network. Board Directors promote an atmosphere where research excellence and industry expertise unite to provide socio-economic benefits for Canadians. The BoD is responsible for the overall governance of the Network and acts in accordance with the By-Laws of AllerGen NCE Inc.

AllerGen’s BoD ensures that Network management pursues appropriate corporate directions and develops, maintains and implements investments, processes and strategic plans in accordance with Network policies and priorities.

Former Board Members

Current Board Members

Pieter Cullis (Chair) | academic/research, Vancouver BC

Pieter Cullis, PhD, FRSC (Chair)

Director, Life Sciences Institute; Director, NanoMedicines Research Group; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology, The University of British Columbia

Dr. Cullis is an internationally recognized pioneer and leader in the physical properties and functional roles of lipids in biological membranes and liposomal drug delivery systems.

Sector: Academic/Research

Christine Hampson (Vice-Chair) | non-profit, Toronto ON

Christine Hampson, PhD

President and CEO, The Sandbox Project

Dr. Hampson is President & CEO of The Sandbox Project Charity, which aims to make measurable progress against international health indicators within the next five years, improving health outcomes with respect to injury prevention, obesity, mental health, and the environment in particular.

Sector: Non-Profit

Judah Denburg | clinical/academic, Hamilton ON

Judah Denburg, MD, FRCP(C)

Scientific Director and CEO, AllerGen NCE Inc.

As Scientific Director of AllerGen, Dr. Denburg helps steer an innovative and inter-disciplinary research program. Dr. Denburg’s main research thrusts include examination of the mechanisms of allergic inflammation, with particular emphasis on hemopoietic cytokines and their role in activating the differentiation and recruitment of inflammatory cells such as eosinophils, basophils and mast cells.

Sector: Clinical/Academic

Vanessa Foran | non-profit, Toronto ON

Vanessa Foran

President and CEO, Asthma Canada

Ms Foran is President and CEO of Asthma Canada, which provides information and services to help the 3 million Canadians with asthma.

Sector: Non-Profit

Charles Frankish | clinical, Kanata ON

Charles Frankish, MD, FRCP(C)

Treasurer, Canadian Allergy, Asthma and Immunology Foundation (CAAIF); Allergist and Clinical Immunologist, Kanata Allergy Services

Dr. Frankish is an allergist and clinical immunologist at Kanata Allergy Services in Kanata, ON.

Sector: Clinical

Jean-François LePrince | private, Montreal QC

Jean-François LePrince

Managing Partner, CTI Life Sciences Fund

Mr. Leprince has over 30 years of experience with large pharmaceutical companies; he has overseen the largest R&D spending of any of the multinational pharmaceutical companies operating in Canada.

Sector: Private

Daniel Nixon | private, Toronto ON

nixonDaniel Nixon, MBA

Director & Chief Financial Officer, Molecular You Corporation

Mr. Nixon is a seasoned executive with extensive private equity, investment banking and operations experience.

Sector: Private

Paul O'Byrne | clinical/academic, Hamilton ON


Professor, Division of Respirology, Department of Medicine, and Dean and Vice-President, Faculty of Health Sciences, McMaster University, St. Joseph’s Healthcare

Dr. O’Byrne is world renowned for his research on asthma that is the result of allergies.

Sector: Clinical/Academic

Diana Royce | AllerGen NCE

Diana Royce, EdD

President and CEO, AllerGen NCE Inc.

Dr. Royce has over 30 years of experience in the post-secondary and health sectors related to public consultation and research, program implementation, strategic and operational planning, network administration, partnership and public policy development, advocacy, fundraising, knowledge mobilization, conference planning and meeting facilitation.

Donald Stark | clinical/academic, Vancouver BC

Donald Stark, MD, FRCP(C)

Clinical Associate Professor, Department of Medicine, The University of British Columbia

Dr. Stark was president of the Canadian Society of Allergy and Clinical Immunology from 1990 to 1992 and was instrumental in setting up the Canadian Allergy, Asthma and Immunology Foundation, serving as its first Chairman.

Sector: Clinical/Academic

Padmaja Subbarao | clinical/academic, Toronto, ON

Padmaja Subbarao, MD, FRCPC, Msc. (Epid)

Director, Pulmonary Function Laboratory, and Clinician-Scientist, Respirologist, Hospital for Sick Children; Associate Professor, Department of Paediatrics, University of Toronto; Director, CHILD Cohort Study

Dr. Subbarao’s primary research interest is in the early determinants and development of asthma. Specifically, she is studying changes in infant lung function biomarkers of inflammation in this understudied group to elucidate the effect of environment and viruses on the early development of disease.

Sector: Clinical/Academic

Lorne Tyrrell | clinical/academic, Edmonton, AB

Lorne Tyrrell, OC, AOE, MD, PhD, FRCP(C), FRSC, FCAHS

Distinguished University Professor and Director, LiKaShing Institute of Virology, University of Alberta

Dr. Tyrrell, an exceptional teacher, compassionate physician and accomplished researcher, has positioned the University of Alberta and Canada as a world leader in hepatitis research and treatment. He was awarded a Killam Prize in 2015.

Sector: Clinical/Academic

Laura Feldman (observer) | AllerGen NCE

Laura Feldman, MPHfeldman (observer)

President, ASNPN

Laura received her B.Sc. in Environment and Health from The University of Toronto in 2014, and her Masters of Public Health degree from The Dalla Lana School of Public Health, University of Toronto, in 2016. Laura is presently working with Dr. Teresa To at the Hospital for Sick Children.

Pascal Marchand (observer) | NCE Secretariat

Pascal Marchand (observer)

Program Manager, NCE Secretariat